WeedMD Inc. produces, distributes, and sells medical-grade cannabis in Canada. More Details
High growth potential and fair value.
Share Price & News
How has WeedMD's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: WMD is more volatile than 75% of Canadian stocks over the past 3 months, typically moving +/- 19% a week.
Volatility Over Time: WMD's weekly volatility (19%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
7 Day Return
1 Year Return
Return vs Industry: WMD underperformed the Canadian Pharmaceuticals industry which returned 100.4% over the past year.
Return vs Market: WMD underperformed the Canadian Market which returned 37.1% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is WeedMD's share price compared to the market and industry in the last 5 years?
Simply Wall St News
4 weeks ago | Simply Wall StWeedMD's (CVE:WMD) Stock Price Has Reduced 78% In The Past Three Years
4 months ago | Simply Wall StWeedMD Inc. (CVE:WMD) On The Verge Of Breaking Even
7 months ago | Simply Wall StIf You Had Bought WeedMD's (CVE:WMD) Shares A Year Ago You Would Be Down 76%
Is WeedMD undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: WMD (CA$0.3) is trading below our estimate of fair value (CA$3.59)
Significantly Below Fair Value: WMD is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: WMD is unprofitable, so we can't compare its PE Ratio to the CA Pharmaceuticals industry average.
PE vs Market: WMD is unprofitable, so we can't compare its PE Ratio to the Canadian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate WMD's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: WMD is good value based on its PB Ratio (0.4x) compared to the CA Pharmaceuticals industry average (2.8x).
How is WeedMD forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: WMD is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.5%).
Earnings vs Market: WMD is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: WMD's is expected to become profitable in the next 3 years.
Revenue vs Market: WMD's revenue (26.2% per year) is forecast to grow faster than the Canadian market (7.3% per year).
High Growth Revenue: WMD's revenue (26.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if WMD's Return on Equity is forecast to be high in 3 years time
How has WeedMD performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: WMD is currently unprofitable.
Growing Profit Margin: WMD is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: WMD is unprofitable, and losses have increased over the past 5 years at a rate of 39.9% per year.
Accelerating Growth: Unable to compare WMD's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: WMD is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (1.2%).
Return on Equity
High ROE: WMD has a negative Return on Equity (-10.72%), as it is currently unprofitable.
How is WeedMD's financial position?
Financial Position Analysis
Short Term Liabilities: WMD's short term assets (CA$96.2M) exceed its short term liabilities (CA$13.6M).
Long Term Liabilities: WMD's short term assets (CA$96.2M) exceed its long term liabilities (CA$75.1M).
Debt to Equity History and Analysis
Debt Level: WMD's debt to equity ratio (50.3%) is considered high.
Reducing Debt: WMD's debt to equity ratio has increased from 1.4% to 50.3% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: WMD has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if WMD has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
What is WeedMD current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate WMD's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate WMD's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if WMD's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if WMD's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of WMD's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
George Scorsis (44 yo)
Mr. George Scorsis has been Executive Chair of WeedMD Inc since December 23, 2019 and Chief Executive Officer since 2021. He served as an Interim Chief Executive Officer from January 4, 2021 to 2021. He ha...
CEO Compensation Analysis
Compensation vs Market: George's total compensation ($USD141.17K) is about average for companies of similar size in the Canadian market ($USD156.56K).
Compensation vs Earnings: Insufficient data to compare George's compensation with company performance.
Experienced Management: WMD's management team is not considered experienced ( 1.4 years average tenure), which suggests a new team.
Experienced Board: WMD's board of directors are not considered experienced ( 1.1 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 17.3%.
WeedMD Inc.'s company bio, employee growth, exchange listings and data sources
- Name: WeedMD Inc.
- Ticker: WMD
- Exchange: TSXV
- Founded: NaN
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: CA$73.987m
- Shares outstanding: 246.62m
- Website: https://www.weedmd.com
Number of Employees
- WeedMD Inc.
- 250 Elm Street
- N5H 2M8
WeedMD Inc. produces, distributes, and sells medical-grade cannabis in Canada. It offers dried cannabis, cannabis plants and seeds, cannabis oil, edibles, extracts and topicals, and others, as well as cann...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/05/07 22:36|
|End of Day Share Price||2021/05/07 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.